http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2610557-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4cc81c2c7423144bfbb39c9cdfdb4361
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-007
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
filingDate 2016-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3283cb9fb67c3655db446828a0555d5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8b919308a3981a4a82d8b3623bcac03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb53dbcca213d549ff4f39a66b45e68a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_567df7a14ef276cd9151d1b2f00b4b25
publicationDate 2017-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2610557-C1
titleOfInvention Method for prevention of excessive scarring of dacryostoma after dacryocystorhinostomy
abstract FIELD: medicine. n SUBSTANCE: invention relates to medicine, namely to ophthalmology, and is intended for prevention of excessive scarring of dacryostoma after dacryocystorhinostomy. For this purpose mitomycin-C solution in concentration 0.2 mg/ml is introduced into lacrimal sac mucosa in dose 0.1 ml in 4 points on perimeter of bone "window" preliminarily before opening medial wall of lacrimal sac. Mitomycin-C solution is also introduced into nasal mucosa around dacryostoma after its formation in dose 0.1 ml in 6 points. n EFFECT: invented method provides reduction of intensity of dacryostoma scarring processes both from nasal mucosa and from lacrimal sac mucosa with reduction of number of recurrences after dacryocystorhinostomy. n 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2724285-C1
priorityDate 2016-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2440072-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2289353-C2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5746
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474858

Total number of triples: 25.